Children & Adolescents
Children & Adolescents
Efavirenz More Effective than Nevirapine for Children with HIV
- Details
- Category: Approved HIV Drugs
- Published on Thursday, 09 May 2013 00:00
- Written by Children’s Hospital of Philadelphia
HIV positive African children and adolescents treated with efavirenz (Sustiva) were less likely to experience virological failure than those using nevirapine (Viramune), according to a large comparative study published in the May 1, 2013, Journal of the American Medical Association. Nevirapine, however, is less expensive and more widely available for children in low-income countries.
FDA Approves Efavirenz (Sustiva) for HIV+ Children Ages 3 Months to 3 Years
- Details
- Category: HIV Treatment
- Published on Friday, 03 May 2013 00:00
- Written by Bristol-Myers Squibb
The U.S. Food and Drug Administration (FDA) announced on May 3 that it has approved a supplemental new drug application for use of efavirenz (Sustiva) by infants and young children with HIV. The new dosing recommendation includes the option to sprinkling capsule contents on food for children who are unable to swallow pills.
April 10 is National Youth HIV and AIDS Awareness Day
- Details
- Category: Children & Adolescents
- Published on Wednesday, 10 April 2013 00:00
- Written by Liz Highleyman
Wednesday, April 10, is the first-ever National Youth HIV + AIDS Awareness Day, an occasion to raise awareness of the epidemic among young people in the U.S.
Antiretroviral Therapy May Have Protective Effect on HIV+ Children's Hearts
- Details
- Category: HIV Treatment
- Published on Wednesday, 24 April 2013 00:00
- Written by NIH
Long-term use of combination antiretroviral therapy (ART) does not impair heart function in children and adolescents with perinatal HIV infection, and in fact appears to have a "cardioprotective" effect, according to a study published in the April 22, 2013, advance online edition of JAMA Pediatrics.
CROI 2013: HIV Treatment for Children Safe and Highly Effective without Laboratory Monitoring
- Details
- Category: HIV Treatment
- Published on Thursday, 07 March 2013 00:00
- Written by Keith Alcorn
Children did just as well on antiretroviral therapy (ART) without routine laboratory monitoring of CD4 cell counts or drug side effects as those who received regular monitoring during 4 years of follow-up, researchers from Uganda and Zimbabwe reported at March 6 the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.
More Articles...
- Young Adults Account for One-quarter of New U.S. HIV Cases, Majority Not Aware of Status
- HIV11: Infants Who Start Antiretrovirals Early Keep HIV Suppressed Despite Treatment Interruption
- HHS Updates Antiretroviral Treatment Guidelines for Children with HIV
- AIDS 2012: New Antiretrovirals Formulations for Children Are Promising, More Still Needed
Web Design and Development by